-transparent.png){kind=logo}
Evidence of developmental toxicity of clinically used nondepolarizing muscle relaxants was sought in rat embryos grown in culture. Embryos were explanted at 8 AM on day 9 of gestation (presomite stage, plug day = day 0), and were cultured in rotating bottles with medium containing various concentrations of d-tubocurarine, pancuronium, atracurium, and vecuronium. At 10 AM on day 11 of gestation (forelimb bud stage), culture was terminated and embryos were examined for general morphology. Treatment with tested agents resulted in dose-dependent developmental toxicity; namely, growth retardation seen as decreased crown-rump length, decreased number of somite pairs, and morphologic abnormalities. However, the concentrations that caused toxicity were at least 30-fold greater than serum concentrations clinically achieved in the mother. We conclude that these muscle relaxants have a low potential for causing developmental toxicity during organogenesis.
M Fujinaga, and
J M Baden, and
R I Mazze
January 1999,
Teratogenesis, carcinogenesis, and mutagenesis,
M Fujinaga, and
J M Baden, and
R I Mazze
January 1997,
Anesthesiology,
M Fujinaga, and
J M Baden, and
R I Mazze
January 1993,
The Yale journal of biology and medicine,
M Fujinaga, and
J M Baden, and
R I Mazze
January 1998,
Eksperimental'naia i klinicheskaia farmakologiia,
M Fujinaga, and
J M Baden, and
R I Mazze
May 1993,
Toxicology in vitro : an international journal published in association with BIBRA,
M Fujinaga, and
J M Baden, and
R I Mazze
September 2004,
European journal of anaesthesiology,
M Fujinaga, and
J M Baden, and
R I Mazze
November 1990,
Anaesthesia and intensive care,
M Fujinaga, and
J M Baden, and
R I Mazze
January 1959,
Anesthesia and analgesia,
M Fujinaga, and
J M Baden, and
R I Mazze
May 1997,
The Annals of pharmacotherapy,
M Fujinaga, and
J M Baden, and
R I Mazze
October 2008,
Anatomia, histologia, embryologia,
